|
|
Media partners 
We work with leading magazines and publishers in this arena. If you are interested in becoming a media partner for this event please contact:
Julie Phillips, Marketing Manager
Email: julie.phillips@terrapinn.com
Tel: 02075394336
Fax: 02072421508
|
Piribo is the source for information products for the global biotechnology, healthcare and pharmaceutical industries.
Use Piribo to browse thousands of business information studies, market reports and books. Find the research you need in your work
BioWorld Europe is an innovative magazine for Life Science clusters, commercial and not-for-profit organisations. Its mission is to provide decision-makers in the European biotech industry with thoroughly compiled news, comprehensive background of recent developments, and practical management resources.
BioWorld Europe is pure B2B-communication. It is unique in providing both, an overview on a specific topic – the editorial focus – and in depth coverage on a determined biotech hot spot – the regional focus (see editorial calendar below). Up to two thirds of the magazines total editorial content is dedicated to these specified focus areas.
Thus, current research and technology is related to the people, the organisations and their places. This guarantees for readers, sponsors and advertisers alike that each issue has a high informative value. This value is maximized with an efficiently targeted distribution: each single issue is adjusted to the markets’ needs!
EUROPEAN BIOTECHNOLOGY Science & Industry News:
The attractive information environment of this monthly published magazine constitutes of thoroughly researched news from science and industry, background reports on new EU legislation, current debates and financing initiatives from Brussels, as well as market analyses on the strengths and weaknesses of European biotech nations and previews on upcoming technology trends. With the European Biotechnology News journal you can address a competent an specialized readership in all 25 EU member states, as well as in Switzerland and Norway, predominantly in the major biotech clusters, in renowned European research institutions, as well as the current members of the 13 national scientific and corporate associations and readers in the biotechnology and Life Sciences industry sector.
Biopharm International is the #1 magazine devoted to the science, strategies and business trends shaping the global landscape for biotherapeutics. Biopharm's focus on applied technologies utilized in biopharmaceutical development and its focus on the business forces driving the industry's growth has attracted a BPA-qualified, global audience of 29,200.
BIOforum Europe provides the European biotechnology and life sciences markets with everything they need to know about the latest in research and development. It offers a pan-European platform for products and developments and therefore also the possibility of both setting up valuable new customer contacts as well as opening up new possibilities for cooperation. Its high-quality articles from the area of applied research, reports on new methods and applications, interviews, profiles of companies and bio regions, and news reports offer the ideal environment to reach the target customers.
Each year the CTI supports several hundred bottom-up R&D projects, executed in collaboration between companies and non-profit research institutions. It funds the services provided by for example; the Federal Institutes of Technology, conventional universities, and the Universities of Applied Sciences (UAS) etc, paying the salaries of the researchers. Its initiative venturelab has set out to sensitize entrepreneurship in Switzerland by offering various course modules. Furthermore, CTI Start-up promotes the development of new technology-based companies with a high growth potential by providing free professional coaching.
The two main focuses of CTI Life Sciences are biotechnology (CTI Biotech) and medical technology (CTI MedTech).
CTI Life Sciences promotes innovation in these sectors by building bridges between the laboratory and the market; In a CTI Life Sciences project the partnering enterprises benefit from the scientific contributions of the institutes. SMEs with limited research budgets may tap into academic R&D services and infrastructures to bring their innovative products faster to the market. Moreover, CTI Life Sciences funds discovery projects.
The CTI has funded 4,500 projects since 1986. Since 1996, more than 1,000 start-up proposals have been evaluated, with over 120 teams being awarded the prestigious CTI Start-up Label.
Drug Delivery Insight: a complete review of the latest commercial and product developments.
Drug Delivery Insight (DDI) takes the hard work out of staying in touch with the companies, products, alliances and research activities shaping the industry. For more information on DDI and to download your free copy visit http://www.espicom.com/ddi
London Technology Network (LTN) is funded by the UK Government, the European Union and three Regional Development Agencies (LDA, EEDA and SEEDA) and has the mission to “stimulate the transfer of technology-based innovation”.
LTN links companies worldwide with the technology research base and innovation capacity of the region’s academic and business communities. Since 2002, LTN has recruited a network of research scientists from over 130 leading research departments covering medical/life and computing/physical/engineering sciences and design. This gives LTN knowledge of, and access to, over 6,000 research scientists and their students. LTN works with these scientists, their colleagues and knowledge transfer offices to accelerate knowledge transfer between academia and industry.
LTN also operates the ‘London Innovation Relay Centre’ allowing it to match both innovation supply and innovation demand of London’s companies to partners throughout the EU.
Link to www.ltnetwork.org and www.london-irc.org
SCREENING - Trends in Drugs Discovery focuses new trends and developments in drug discovery. SCREENING covers all aspects of research as well as strategies of pharmaceutical companies and start-up companies. This editorial mixture makes for relevant reading for all those concerned with drug discovery. SCREENING - Trends in Drugs Discovery is published in English with 4 editions in 2006. For more information please contact Dr. Jutta van Empel at j.empel@gitverlag.com or tel. +49 6151 8090-139.
Journal of Commercial Biotechnology aims to be the leading publication in its field by increasing practical understanding of the strategic development and management associated with the commercialisation of biotechnology. It seeks to provide a peer-reviewed, international forum for the dissemination and evaluation of the current techniques, strategic thinking and best practice in all aspects of the subject.
World Scientific Publishing publishes Asia Pacific Biotech News (APBN), the first and only fortnightly report on pharmaceutical, medical, agricultural and environmental sciences in Asia Pacific. APBN is a premium magazine providing industry professionals and experts with breaking news and updates on biotechnology in Asia Pacific. With its rich contents accompanied by insightful and in-depth reports, APBN is widely read by professionals and researchers in the biotechnology sector around the world. Our magazine has a wide reach to the life sciences and biotech community and is present in major conferences in the region. Please visit http://www.asiabiotech.com
Bentham Science Publishers, a major STM journal publisher of 79 titles in 2007, answers the information needs of the pharmaceutical, bio and medical research community. Leading journals include Current Drug Metabolism (Impact Factor 5.4) and Current Pharmaceutical Design (Impact Factor 4.8) :
*FREE online journals and information: www.bentham.org
*Subscribe, Consortia, discounted global licenses and trials: subscriptions@bentham.org
In-PharmaTechnologist.com provides professionals in the industry every day with the latest breaking news on technology and its implications for pharmaceutical manufacturing. This leading online publication allows its readers to focus clearly on the news that affects them and helps drive their business decisions. Join our subscriber base and receive your FREE newsletter now!
BioPharmareporter.com is the leading B2B strategic news resource for the biopharmaceutical market, providing key decision makers and industry professionals with the crucial market intelligence and latest breaking news across Europe, America and Asia Pacific. Subscribe now for the FREE e-newsletter of this complete information source within the pharmaceutical industry.
Outsourcing-pharma.com is the leading B2B online strategic news resource for the pharmaceutical industry, enabling industry professionals and key decision makers to keep ahead of breaking news worldwide. Outsourcingpharma.com provides a strong platform of communication for industry professionals, encompassing bespoke marketing strategies to compliment your company’s business objectives.
|
|
|
|
